search icon
Join IDSAJOIN IDSA >> Go to MyIDSAGO TO MYIDSA >>
  • What's New in Practice Management & Payment

    Now Available: MIPS Performance Feedback, Final Score, and Targeted Review

    MIPS Reporting Deadlines Fast Approaching: 10 Things to Do and Know

    CMS MIPS Data Submission Portal Now Available

    2016 Physician Compare Data Now Available

    AMA Releases an Interactive Web-based Tool for MIPS

  • 2018 ID Week logo final
  • Read the Latest from Science Speaks: Global ID News


  • UNAIDS global HIV data shows “miles to go”

    An affirmation on the way to AIDS 2018: Much has changed, not enough, and some for the worse

    What we’re reading: How to pick fights against diseases and win

  • News from IDSA and Journals

    7/19/2018

    Pandemic Preparedness Bill Addresses Critical Gaps

    Read More >>

    With a key provision supporting the development of a trained and ready public health workforce, and new efforts to combat antimicrobial resistance, the Pandemic and All Hazards Preparedness Act reauthorization bill approved by the House Energy and Commerce Committee Wednesday addresses issues that are essential to ensuring we have the resources and capacities we will need to confront emerging threats to public health.

  • CDC and FDA Alerts

    5/30/2018 2:01:35 PM

    CDC: Update on Ebola Virus Disease Outbreak in Democratic Republic of Congo

    On May 8, 2018, the Ministry of Public Health (MoHP) of Democratic Republic of the Congo (DRC) declared an outbreak of Ebola virus disease (EVD) in Bikoro Health Zone, Equateur Province, in Northwest DRC.

    5/14/2018 4:14:45 PM

    Auromedics Pharma LLC Issues Voluntary Nationwide Recall

    AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level.

    4/26/2018 2:46:41 PM

    Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction

    The FDA is warning that the medicine Lamictal (lamotrigine) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system.

    3/6/2018 2:47:49 PM

    Updated Influenza and Hep A Vaccine Resolutions

    In February 2018, ACIP updated influenza vaccine and hepatitis A vaccine resolutions for the Vaccines for Children Program. The changes are:

    2/20/2018 2:47:27 PM

    Multistate Outbreak of Salmonella

    CDC, public health and regulatory officials in several states, and the U.S. Food and Drug Administration (FDA) are investigating a multistate outbreak of Salmonella I 4,[5],12:b:- infections.

    1/19/2018 11:25:10 AM

    Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall - Presence of Visible Particulate Matter

    AuroMedics Pharma LLC is voluntarily recalling one lot of Levofloxacin in 5% Dextrose Injection 250mg/50mL in a Single-Use flexible container NDC 55150-243-46, Lot CLF160003, Expiry date May 2018, to the hospital level.

    1/8/2018 4:51:03 PM

    Early Season Influenza A(H3N2) Activity and Treatment of Patients with Influenza Antiviral Medications

    The Centers for Disease Control and Prevention (CDC) is providing: 1) a notice about increased influenza A(H3N2) activity and its clinical implications; 2) a summary of influenza antiviral drug treatment recommendations; 3) an update about approved treatment drugs and supply this season; and 4) background information for patients about influenza treatment.

    12/28/2017 4:54:06 PM

    CDC Investigating Multistate Outbreak of E. coli O157:H7 Infections

    CDC, several states, and the U.S. Food and Drug Administration are investigating a multistate outbreak of Shiga toxin-producing E. coli O157:H7 infections (STEC O157:H7) in 13 states. Seventeen illnesses have been reported from California (3), Connecticut (2), Illinois (1), Indiana (1), Michigan (1), Nebraska (1), New Hampshire (2), New York (1), Ohio (1), Pennsylvania (1), Virginia (1), Vermont (1) and Washington (1).

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site